EUVIMEDEUVIMED entdecken
Crossref

AKT1 participates in ferroptosis vulnerability by driving autophagic degradation of FTH1 in cisplatin-resistant ovarian cancer

Zhikun Shi iD, Hao Yuan, Lanqing Cao, Yang Lin

Biochemistry and Cell Biology · 2023

DOI: 10.1139/bcb-2022-0361 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemistry and Cell Biology, 2023. Verfasst von Zhikun Shi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, the Second Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Ferroptosis, Ovarian Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Resistance to cisplatin (DDP)-based chemotherapy is an important reason for the failure of ovarian cancer treatment. However, tumor cells resistant to chemotherapy may expose vulnerability to other cell death pathways. Here, we found that DDP-resistant ovarian cancer cells are more susceptible to erastin-induced ferroptosis. It should be noted that this vulnerability does not depend on the weakening of classical ferroptosis defense proteins, but is caused by the reduction of ferritin heavy chain (FTH1). DDP-resistant ovarian cancer cells maintain a high level of autophagy to escape the pressure of chemotherapy, which ultimately leads to increased autophagic degradation of FTH1. We further revealed that the loss of AKT1 was the reason for the increased autophagy level of DDP-resistant ovarian cancer cells. Our study provides new insights into reversing DDP resistance in ovarian cancer by targeting ferroptosis pathway, and AKT1 may be a molecular marker of susceptibility to ferroptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisOvarian NeoplasmsFemaleHumansApoptosisAutophagyCell Line, TumorCisplatinDrug Resistance, NeoplasmFerritinsProto-Oncogene Proteins c-aktOxidoreductases

Stichwörter der Autor:innen

AKT1FTH1autophagychemoresistanceferroptosisovarian cancer

Substanzen

CisplatinFerritinsProto-Oncogene Proteins c-aktAKT1 protein, humanFTH1 protein, humanOxidoreductases

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, the Second Hospital of Jilin University, Changchun, China.
  • Department of Prosthetic Dentistry, Hospital of Stomatology, Jilin University, Changchun, China.
  • Department of Pathology, the Second Hospital of Jilin University, Changchun, China.

ORCID-Profile: Zhikun Shi

Zitieren

APA

Shi, Z., Yuan, H., Cao, L., & Lin, Y. (2023). AKT1 participates in ferroptosis vulnerability by driving autophagic degradation of FTH1 in cisplatin-resistant ovarian cancer. Biochemistry and Cell Biology. https://doi.org/10.1139/bcb-2022-0361

Vancouver

Shi Z, Yuan H, Cao L, Lin Y. AKT1 participates in ferroptosis vulnerability by driving autophagic degradation of FTH1 in cisplatin-resistant ovarian cancer. Biochemistry and Cell Biology. 2023. doi:10.1139/bcb-2022-0361

BibTeX
@article{Shi2023,
  author = {Shi, Zhikun and Yuan, Hao and Cao, Lanqing and Lin, Yang},
  title = {AKT1 participates in ferroptosis vulnerability by driving autophagic degradation of FTH1 in cisplatin-resistant ovarian cancer},
  journal = {Biochemistry and Cell Biology},
  year = {2023},
  doi = {10.1139/bcb-2022-0361}
}
Kostenlos starten →